1. Ethics in the Gleevec Story
... diagnosed with disease and others who can potentially be exposed in their lifetimes. There is a very fine balance that regulating authorities like the FDA have to tread to make sure the common good of the people, not one person's individual benefit. When a patient facing death demands the right to an experimental drug, is it responsible to give them a chance or is it necessary to prioritize ... the impact that decision can have on millions of other patients and their families in the larger global community. Drugs can be harmful for a number ... elevated white blood cell count; a normal...
- Word Count: 1533
- Approx Pages: 6
- Grade Level: Undergraduate